AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
DICLOFENAC POTASSIUM 50.000 Mg ;
11 registrations across 1 African market— 11 active
Markets with DICLOFENAC POTASSIUM 50.000 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| RAPIDUS Film Coated Tablets | 🇪🇬Egypt | Tabuk Pharmaceutical Manufacturing Co.Egypt - local under construction | active | — |
| DICLORAPID Film Coated Tablets | 🇪🇬Egypt | Spimaco Misr for pharmaceutical industries | active | — |
| Dicloflam 50mg Sugar Coated Tablets | 🇪🇬Egypt | Alexandria Co. For Pharmaceuticals and Chemical Industries | active | — |
| Femtocina Granules in sachets for oral solution | 🇪🇬Egypt | Medicina health care | active | — |
| Rapidinix Granules for Oral Solution | 🇪🇬Egypt | Globe Tec Pharmaceuticals | active | — |
| Inestafenac Granules for Oral Solution | 🇪🇬Egypt | South Egypt Drug Industries Co (SEDICO) | active | — |
| Dicloflam 50mg Sugar Coated Tablets | 🇪🇬Egypt | Alexandria Co. For Pharmaceuticals and Chemical Industries | active | — |
| UNIRAPECURE Film Coated Tablets | 🇪🇬Egypt | universal pharmaceutical industries (unipharma) | active | — |
| Rapidinix Granules for Oral Solution | 🇪🇬Egypt | Globe Tec Pharmaceuticals | active | — |
| Inestafenac Granules for Oral Solution | 🇪🇬Egypt | South Egypt Drug Industries Co (SEDICO) | active | — |
| Femtocina Granules in sachets for oral solution | 🇪🇬Egypt | Medicina health care | active | — |
DICLOFENAC POTASSIUM 50.000 Mg ; in Africa — Regulatory Overview
DICLOFENAC POTASSIUM 50.000 Mg ; is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.